Cargando…
Regulatory Crosstalk of Doxorubicin, Estradiol and TNFα Combined Treatment in Breast Cancer-derived Cell Lines
We present a new model of ESR1 network regulation based on analysis of Doxorubicin, Estradiol, and TNFα combination treatment in MCF-7. We used Doxorubicin as a therapeutic agent, TNFα as marker and mediator of an inflammatory microenvironment and 17β-Estradiol (E2) as an agonist of Estrogen Recepto...
Autores principales: | Nassiri, Isar, Inga, Alberto, Meškytė, Erna Marija, Alessandrini, Federica, Ciribilli, Yari, Priami, Corrado |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811586/ https://www.ncbi.nlm.nih.gov/pubmed/31645610 http://dx.doi.org/10.1038/s41598-019-51349-9 |
Ejemplares similares
-
MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis
por: Meškytė, Erna Marija, et al.
Publicado: (2020) -
ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells()
por: Alessandrini, Federica, et al.
Publicado: (2018) -
ETV7 regulates breast cancer stem-like cell features by repressing IFN-response genes
por: Pezzè, Laura, et al.
Publicado: (2021) -
Whole-genome cartography of p53 response elements ranked on transactivation potential
por: Tebaldi, Toma, et al.
Publicado: (2015) -
ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis
por: Meškytė, Erna Marija, et al.
Publicado: (2023)